Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kei Irie

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|July 14, 2025
Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
The Journal of Applied Laboratory Medicine|March 25, 2025
Volumetric Absorptive Microsampling Combined with Mass Spectrometry to Support Pharmacokinetically-Guided Precision Dosing of Mycophenolate Mofetil in Pediatric Lupus Nephritis PatientsJunfang Zhao, Xueheng Zhao, Tomoyuki Mizuno, et al.
Clinical Pharmacology and Therapeutics|November 5, 2025
Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Therapeutic Drug Monitoring|June 3, 2025
Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World DataKei Irie, Phillip Minar, Jack Reifenberg, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Clinical and Translational Science|June 1, 2020
Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID-19Kei Irie, Atsushi Nakagawa, Hirotoshi Fujita, et al.
Journal of Cardiology Cases|November 14, 2019
Atrial fibrillation observed in a patient with esophageal cancer treated with fluorouracilShohei Moriyama, Taku Yokoyama, Kei Irie, et al.
Investigational New Drugs|September 18, 2023
Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myelomaKenta Yamaoka, Kei Irie, Nobuhiro Hiramoto, et al.
Frontiers in Pharmacology|June 6, 2022
Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving EnzalutamideMasaki Hirabatake, Hiroaki Ikesue, Yuna Iwama, et al.
Arthritis Research & Therapy|December 31, 2025
Give weekly adalimumab a chance before discontinuing it: a retrospective clinical and pharmacokinetic analysis in pediatric rheumatologyFrancesca Burlo, Serena Pastore, Gabriele Stocco, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|July 14, 2025
Hybrid Population PK-Machine Learning Modeling to Predict Infliximab Pharmacokinetics in Pediatric and Young Adult Patients with Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
The Journal of Applied Laboratory Medicine|March 25, 2025
Volumetric Absorptive Microsampling Combined with Mass Spectrometry to Support Pharmacokinetically-Guided Precision Dosing of Mycophenolate Mofetil in Pediatric Lupus Nephritis PatientsJunfang Zhao, Xueheng Zhao, Tomoyuki Mizuno, et al.
Clinical Pharmacology and Therapeutics|November 5, 2025
Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Therapeutic Drug Monitoring|June 3, 2025
Machine Learning Modeling for Predicting Infliximab Pharmacokinetics in Pediatric and Young Adult Patients With Crohn Disease: Leveraging Ensemble Modeling With Synthetic and Real-World DataKei Irie, Phillip Minar, Jack Reifenberg, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Model-informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn's DiseaseKei Irie, Phillip Minar, Jack Reifenberg, et al.
Clinical and Translational Science|June 1, 2020
Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID-19Kei Irie, Atsushi Nakagawa, Hirotoshi Fujita, et al.
Journal of Cardiology Cases|November 14, 2019
Atrial fibrillation observed in a patient with esophageal cancer treated with fluorouracilShohei Moriyama, Taku Yokoyama, Kei Irie, et al.
Investigational New Drugs|September 18, 2023
Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myelomaKenta Yamaoka, Kei Irie, Nobuhiro Hiramoto, et al.
Frontiers in Pharmacology|June 6, 2022
Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving EnzalutamideMasaki Hirabatake, Hiroaki Ikesue, Yuna Iwama, et al.
Arthritis Research & Therapy|December 31, 2025
Give weekly adalimumab a chance before discontinuing it: a retrospective clinical and pharmacokinetic analysis in pediatric rheumatologyFrancesca Burlo, Serena Pastore, Gabriele Stocco, et al.
Pageof 6